Gupta et al. showed the anti-proliferative effects of CuB against breast cancer cells at low concentrations, ranging from 18 to 50 nM, and acting via the downregulation of HER2 and integrin signaling. The gene discussed is ERBB2; the disease is breast carcinoma.